Skip to main content
Caplight Logo









Volnay Therapeutics

Volnay Therapeutics

Cambridge, Massachusettsvolnay.com

Overview

Volnay Therapeutics is a biotech venture builder that creates, funds, and develops ventures in the cell and gene therapy sector.

Year Founded

2022

Portfolio Companies

2

Website

volnay.com

Investments

Volnay Therapeutics investments
CompanyDateStageLead
March BiosciencesOct 2024Series ACo-investor
Alaya.bioDec 2022SeedCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is Volnay Therapeutics based?

Volnay Therapeutics is headquartered in Cambridge, Massachusetts, United States.

When was Volnay Therapeutics founded?

Volnay Therapeutics was founded in 2022.

How many portfolio companies does Volnay Therapeutics have?

Volnay Therapeutics has 2 portfolio companies in Caplight's dataset.

What are some companies in Volnay Therapeutics's portfolio?

Portfolio companies visible on Caplight include March Biosciences, Alaya.bio.

What was Volnay Therapeutics's most recent investment shown here?

Volnay Therapeutics's most recent investment in this portfolio sample was in March Biosciences in 2024.

What sectors does Volnay Therapeutics focus on?

Volnay Therapeutics focuses on Healthcare & Life Sciences, Healthcare & Life Sciences.

What company stages does Volnay Therapeutics focus on?

Volnay Therapeutics typically invests at the Early stage.

Firmographic Details

HeadquartersCambridge, Massachusetts
Year Founded2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?